The Ministry of Health of the Russian Federation in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate LS-001739 dated 19.07.2011 issued by Wörwag Pharma GmbH & Co. KG, Germany):
Lizigamma® (trade name of the medicinal product)
Lisinopril (international non-proprietary or grouping or chemical name)
tablets, 5.0 mg, 10.0 mg, 20.0 mg (dosage form, dosage)
TS.P.M. Contract Pharma GmbH & Co. KG. KG, Germany Fruhlingstrasse 7, 83620 Feldkirchen-Westerham, Germany (name and address of the location of the manufacturer of the medicinal product)
on the basis of an application by the authorized legal entity "Vervag Pharma GmbH & Co. KG" to cancel the state registration of the medicinal product.